Blog Category

Tag: ProNai Therapeutics

Navigate all the resources featured in the Landscape Guide by geographic location, industry sector, and organization type. Landscape Guide
Everything you need to know to make a meaningful first connection can be found in our 2021-22 Landscape Guide! Download the Guide

2023 MVCA Research Report

Our state's entrepreneurial economy hinges on our ability to provide capital to our high-growth, high-potential companies. Download the Report

Upcoming Events

Learn More
November 16 Congratulations Mina Sooch! The Entrepreneur of the Year Award

Serial entrepreneurs are the lifeblood of a vibrant, growing venture capital community, and the Great Lakes Region is home to many successful founders who can translate their past experience into growing new companies in this area.  Over the past decade, one Michigan entrepreneur and venture capitalist has proven she has the determination to nurture multiple […]
Read More
April 24 ProNAi Therapeutics Raises $59.5M Series D Round for Phase II Clinical Trials

ProNAi Therapeutics Inc . has collected $59.5 million after clinical studies showed that its lead drug could help non-Hodgkin’s lymphoma patients who are running out of options.
Read More
November 10 ProNAi Expands Management Team and Presents Encouraging Phase I Study Results for Lead Cancer Drug at Cancer Meeting

ProNAi Therapeutics, Inc., a private DNAi cancer drug development company, recently concluded its initial human clinical trial of PNT2258. The company also expanded its management team with the recent appointments of board member and venture capital investor Mina Sooch, MBA, as President and CEO, and Dr. Richard Messmann, MD, as Chief Medical Officer.
Read More
July 11 MVCA Programs to Attract Investment, Entrepreneur Talent Gaining Traction

The Michigan Venture Capital Association’s (MVCA) programs to develop the state’s investment community are helping venture capitalists and their portfolio companies attract and retain top talent.

Read More